Skip to main content

Market Overview

KalVista Pharmaceuticals, Inc. (KALV)

26.20 +0.19 (0.73%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2022
Pre-Market
EPS:
REV:
-0.56
0



Q2 2022
Pre-Market
EPS:
REV:
-0.58
0



Q1 2022
Pre-Market
EPS:
REV:
-0.61
0



Q4 2021
Pre-Market
EPS:
REV:
-0.37
3.824M



Q3 2021
Pre-Market
EPS:
REV:
-0.52
1.577M

-0.56
0

Q2 2021
Pre-Market
EPS:
REV:
-0.33
3.92M

-0.58
0

Q1 2021
Pre-Market
EPS:
REV:
-0.42
3.369M

-0.61
0

Q4 2020
Pre-Market
EPS:
REV:
-0.49
2.926M

-0.37
3.824M

Q3 2020
Pre-Market
EPS:
REV:
-0.23
3.89M

-0.52
1.577M

Q2 2020
Pre-Market
EPS:
REV:
-0.22
5.592M

-0.33
3.92M

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!